High glucose concentration produces a short-term increase in pERK1/2 and p85 proteins, having a direct angiogenetic effect by an action similar to VEGF.


Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 30 12 2019
accepted: 10 02 2020
pubmed: 5 3 2020
medline: 24 9 2020
entrez: 5 3 2020
Statut: ppublish

Résumé

Excessive glucose serum concentration, endothelial dysfunction and microangiopathy are key features of diabetes mellitus, being both diagnostic parameters and pathogenetic mechanisms. Vascular endothelial growth factor (VEGF) is importantly implicated in the physiology and pathology of blood vessels, including diabetic vascular damage. These factors certainly affect endothelial cells, and to evaluate mechanisms involved, we took advantage of telomerase-immortalized human microvascular endothelial (TIME) cells. TIME cells were exposed to different glucose concentrations and to VEGF treatments. Culture conditions also included the use of basement membrane extract, as an in vitro differentiation model. Cell morphology was then evaluated in the different conditions, and cellular proteins were extracted to analyze specific protein products by Western blot. High glucose concentrations and VEGF did substantially affect neither morphology nor growth of cultured TIME cells, while both considerably increased differentiation into "capillary-like" structures when cells were cultured on basement membrane extract. Under these conditions, high glucose concentration and VEGF also produced a short-term increase in pERK1/2 and p85 proteins, while total and phosphorylated AKT were not affected. These data suggest a direct angiogenetic effect of glucose, affecting intracellular transduction mechanisms with an action similar to that of VEGF. This effect on endothelial cell proliferation and differentiation could be part of pathogenetic mechanisms producing diabetic microvascular alterations.

Identifiants

pubmed: 32130518
doi: 10.1007/s00592-020-01501-z
pii: 10.1007/s00592-020-01501-z
doi:

Substances chimiques

Angiogenesis Inducing Agents 0
Vascular Endothelial Growth Factor A 0
Class Ia Phosphatidylinositol 3-Kinase EC 2.7.1.137
MAPK1 protein, human EC 2.7.11.24
Mitogen-Activated Protein Kinase 1 EC 2.7.11.24
Mitogen-Activated Protein Kinase 3 EC 2.7.11.24
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

947-958

Subventions

Organisme : Ministero dell'Istruzione, dell'Università e della Ricerca
ID : PRIN 200832E9J9_003

Références

Ding J, Liu Y, Sullivan DA (2015) Effects of insulin and high glucose on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci 56:7814–7820
doi: 10.1167/iovs.15-18049
Uemura S, Matsushita H, Li W et al (2001) Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 88:1291–1298
doi: 10.1161/hh1201.092042
Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412
doi: 10.2337/diab.40.4.405
Curcio F, Ceriello A (1992) Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. Vitro Cell Dev Biol 28A:787–790
doi: 10.1007/BF02631069
Wang D, Wang Q, Yan G et al High glucose and interleukin 1β-induced apoptosis in human umbilical vein endothelial cells involves in down-regulation of monocarboxylate transporter 4. Biochem Biophys Res Commun 466:607–614
doi: 10.1016/j.bbrc.2015.09.016
Du X, Matsumura T, Edelstein D et al (2003) Inhibition of GAPDH activity by poly (ADP-ribose) polymerase activates three major pathways of hyper-glycemic damage in endothelial cells. J Clin Investig 112(7):1049–1057
doi: 10.1172/JCI18127
McGinn S, Poronnik P, King M, Gallery ED, Pollock CA (2003) High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity. Am J Physiol Cell Physiol 284(6):C1374–C1386
doi: 10.1152/ajpcell.00466.2002
Shao Y, Li X, Wood JW, Ma J-X (2018) Mitochondrial dysfunctions, endothelial progenitor cells and diabetic retinopathy. J Diabetes Complic 32:966–973. https://doi.org/10.1016/j.jdiacomp.2018.06.015
doi: 10.1016/j.jdiacomp.2018.06.015
Abcouwer SF, Gardner TW (2014) Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment. Ann N Y Acad Sci 1311:174–190. https://doi.org/10.1111/nyas.12412
doi: 10.1111/nyas.12412 pubmed: 24673341 pmcid: 4154702
Adamis AP, Miller JW, Bernal MT et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450
doi: 10.1016/S0002-9394(14)75794-0
Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480–1487. https://doi.org/10.1056/NEJM199412013312203
doi: 10.1056/NEJM199412013312203 pubmed: 7526212
Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE (2000) Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 157(1):135–144
doi: 10.1016/S0002-9440(10)64525-7
Wirostko B, Wong TY, Simó R (2008) Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res 27:608–621. https://doi.org/10.1016/j.preteyeres.2008.09.002
doi: 10.1016/j.preteyeres.2008.09.002 pubmed: 18929676
Wang W, Lo ACY (2018) Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci 19:1816. https://doi.org/10.3390/ijms19061816
doi: 10.3390/ijms19061816 pmcid: 6032159
Hueber A, Wiedemann P, Esser PHK (1996) Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR). Int Ophthalmol 20:345–350
pubmed: 9237137
Haurigot V, Villacampa P, Ribera A et al (2009) Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown. J Biol Chem 284:22961–22969. https://doi.org/10.1074/jbc.M109.014787
doi: 10.1074/jbc.M109.014787 pubmed: 19473988 pmcid: 2755703
Wilkinson-Berka JL, Wraight C, Werther G (2006) The role of growth hormone, insulin-like growth factor and somatostatin in diabetic retinopathy. Curr Med Chem 13:3307–3317
doi: 10.2174/092986706778773086
Patel JI, Hykin PG, Gregor ZJ et al (2005) Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol 89:480–483. https://doi.org/10.1136/bjo.2004.049940
doi: 10.1136/bjo.2004.049940 pubmed: 15774928 pmcid: 1772595
Coxon A, Bready J, Min H et al (2010) Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody. Mol Cancer Ther 9:2641–2651. https://doi.org/10.1158/1535-7163.MCT-10-0213
doi: 10.1158/1535-7163.MCT-10-0213 pubmed: 20937592 pmcid: 4430860
Astaneie F, Afshari M, Mojtahedi A et al (2005) Total antioxidant capacity and levels of epidermal growth factor andnitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 36(4):376–381
doi: 10.1016/j.arcmed.2005.03.007
Eckardt K-U (2009) Erythropoietin and microvascular diabetic complications. Nephrol Dial Transplant 24:388–390. https://doi.org/10.1093/ndt/gfn590
doi: 10.1093/ndt/gfn590 pubmed: 18952703
Karaman S, Leppänen V-M, Alitalo K (2018) Vascular endothelial growth factor signaling in development and disease. Development 145:dev151019. https://doi.org/10.1242/dev.151019
doi: 10.1242/dev.151019 pubmed: 30030240
Venetsanakos E, Mirza A, Fanton C et al (2002) Induction of tubulogenesis in telomerase-immortalized human microvascular endothelial cells by glioblastoma cells. Exp Cell Res 273:21–33. https://doi.org/10.1006/excr.2001.5424
doi: 10.1006/excr.2001.5424 pubmed: 11795943
Yang J, Chang E, Cherry AM et al (1999) Human endothelial cell life extension by telomerase expression. J Biol Chem 274:26141–26148. https://doi.org/10.1074/jbc.274.37.26141
doi: 10.1074/jbc.274.37.26141 pubmed: 10473565
Lee KM, Choi KH, Ouellette MM (2004) Use of exogenous hTERT to immortalize primary human cells. Cytotechnology 45:33–38. https://doi.org/10.1007/10.1007/s10616-004-5123-3
doi: 10.1007/10.1007/s10616-004-5123-3 pubmed: 19003241 pmcid: 3449956
Shao R, Guo X (2004) Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochem Biophys Res Commun 321:788–794. https://doi.org/10.1016/j.bbrc.2004.07.033
doi: 10.1016/j.bbrc.2004.07.033 pubmed: 15358096
Chang MW-F, Grillari J, Mayrhofer C et al (2005) Comparison of early passage, senescent and hTERT immortalized endothelial cells. Exp Cell Res 309:121–136. https://doi.org/10.1016/j.yexcr.2005.05.002
doi: 10.1016/j.yexcr.2005.05.002 pubmed: 15964568
Kashyap MV, Ranjan AP, Shankardas J, Vishwanatha JK (2013) Establishment of human retinal microvascular endothelial cells with extended life-span. In Vivo 27:685–694
pubmed: 24292569
Olofsson B, Porsch H, Heldin P (2014) Knock-down of CD44 regulates endothelial cell differentiation via NFκB-mediated chemokine production. PLoS ONE 9:e90921. https://doi.org/10.1371/journal.pone.0090921
doi: 10.1371/journal.pone.0090921 pubmed: 24614402 pmcid: 3948721
Chung C-H, Wu W-B, Huang T-F (2004) Aggretin, a snake venom-derived endothelial integrin 2 1 agonist, induces angiogenesis via expression of vascular endothelial growth factor. Blood 103:2105–2113. https://doi.org/10.1182/blood-2003-07-2483
doi: 10.1182/blood-2003-07-2483 pubmed: 14630793
Chin H, Horng C, Liu Y et al (2018) Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells. Oncol Rep 39:2351–2357. https://doi.org/10.3892/or.2018.6312
doi: 10.3892/or.2018.6312 pubmed: 29565448
Caputo M, De Rosa MC, Rescigno T et al (2014) Binding of polyunsaturated fatty acids to LXRα and modulation of SREBP-1 interaction with a specific SCD1 promoter element. Cell Biochem Funct 32:637–646. https://doi.org/10.1002/cbf.3067
doi: 10.1002/cbf.3067 pubmed: 25264165
Mortuza R, Chen S, Feng B et al (2013) High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS ONE 8:e54514. https://doi.org/10.1371/journal.pone.0054514
doi: 10.1371/journal.pone.0054514 pubmed: 23342163 pmcid: 3546959
Felice F, Lucchesi D, di Stefano R et al (2010) Oxidative stress in response to high glucose levels in endothelial cells and in endothelial progenitor cells: evidence for differential glutathione peroxidase-1 expression. Microvasc Res 80(3):332–338. https://doi.org/10.1016/j.mvr.2010.05.004
doi: 10.1016/j.mvr.2010.05.004 pubmed: 20471990
Morita K, Sasaki H, Furuse M, Tsukita S (1999) Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147:185–194. https://doi.org/10.1083/jcb.147.1.185
doi: 10.1083/jcb.147.1.185 pubmed: 10508865 pmcid: 2164984
Piehl C, Piontek J, Cording J et al (2010) Participation of the second extracellular loop of claudin-5 in paracellular tightening against ions, small and large molecules. Cell Mol Life Sci 67:2131–2140. https://doi.org/10.1007/s00018-010-0332-8
doi: 10.1007/s00018-010-0332-8 pubmed: 20333434
Shah AV, Birdsey GM, Randi AM (2016) Regulation of endothelial homeostasis, vascular development and angiogenesis by the transcription factor ERG. Vascul Pharmacol 86:3–13. https://doi.org/10.1016/j.vph.2016.05.003
doi: 10.1016/j.vph.2016.05.003 pubmed: 27208692 pmcid: 5404112
Birdsey GM, Shah AV, Dufton N et al (2015) The endothelial transcription factor ERG promotes vascular stability and growth through Wnt/β-catenin signaling. Dev Cell 32:82–96. https://doi.org/10.1016/j.devcel.2014.11.016
doi: 10.1016/j.devcel.2014.11.016 pubmed: 25584796 pmcid: 4292982
Sperone A, Dryden NH, Birdsey GM et al (2011) The transcription factor erg inhibits vascular inflammation by repressing NF-κB activation and proinflammatory gene expression in endothelial cells. Arterioscler Thromb Vasc Biol 31:142–150. https://doi.org/10.1161/ATVBAHA.110.216473
doi: 10.1161/ATVBAHA.110.216473 pubmed: 20966395
Patan S (2004) Vasculogenesis and angiogenesis. Cancer Treat Res 117:3–32
doi: 10.1007/978-1-4419-8871-3_1
Schenone S, Manetti F, Botta M (2007) SRC inhibitors and angiogenesis. Curr Pharm Des 13:2118–2128
doi: 10.2174/138161207781039580
Siemann DW, Horsman MR (2009) Vascular targeted therapies in oncology. Cell Tissue Res 335:241–248. https://doi.org/10.1007/s00441-008-0646-0
doi: 10.1007/s00441-008-0646-0 pubmed: 18752004
Nussenbaum F, Herman IM (2010) Tumor angiogenesis: insights and innovations. J Oncol 2010:132641. https://doi.org/10.1155/2010/132641
doi: 10.1155/2010/132641 pubmed: 20445741 pmcid: 2860112
Lohela M, Bry M, Tammela T, Alitalo K (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21:154–165. https://doi.org/10.1016/j.ceb.2008.12.012
doi: 10.1016/j.ceb.2008.12.012 pubmed: 19230644
Ahluwalia A, Jones MK, Brzozowska I, Tarnawski AS (2017) In vitro model of vasculo-angiogenesis: demonstration that bone marrow derived endothelial progenitor cells form new hybrid capillary blood vessels jointly with gastric endothelial cells. J Physiol Pharmacol 68(6):841–846
pubmed: 29550796
Kern TS, Barber AJ (2008) Retinal ganglion cells in diabetes. J Physiol 586:4401–4408. https://doi.org/10.1113/jphysiol.2008.156695
doi: 10.1113/jphysiol.2008.156695 pubmed: 18565995 pmcid: 2614025
Jindal V (2015) Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy. Mol Neurobiol 51:878–884. https://doi.org/10.1007/s12035-014-8732-7
doi: 10.1007/s12035-014-8732-7 pubmed: 24826918
Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52:1156–1163. https://doi.org/10.1167/iovs.10-6293
doi: 10.1167/iovs.10-6293 pubmed: 21357409 pmcid: 3053099
Di Zazzo E, Feola A, Zuchegna C et al (2014) The p85 regulatory subunit of PI3K mediates cAMP-PKA and insulin biological effects on MCF-7 cell growth and motility. Sci World J. https://doi.org/10.1155/2014/565839
doi: 10.1155/2014/565839
Winnay JN, Kahn CR (2011) PI 3-kinase regulatory subunits as regulators of the unfolded protein response. Methods Enzymol 490:147–158. https://doi.org/10.1016/B978-0-12-385114-7.00009-X
doi: 10.1016/B978-0-12-385114-7.00009-X pubmed: 21266249 pmcid: 4371597

Auteurs

Ferdinando Carlo Sasso (FC)

Department of Advanced Medical and Surgical Sciences, School of Medicine and Surgery, Università Dalla Campania "L. Vanvitelli", Piazza Miraglia 2, 80138, Naples, Italy. ferdinandocarlo.sasso@unicampania.it.

Candida Zuchegna (C)

Department of Biology, University of Naples "Federico II", Via Cinthia, 4, 80126, Naples, Italy. candida.zuchegna@unina.it.

Mario Felice Tecce (MF)

Department of Pharmacy, University of Salerno, Fisciano, Italy.

Anna Capasso (A)

Department of Pharmacy, University of Salerno, Fisciano, Italy.

Luigi Elio Adinolfi (LE)

Department of Advanced Medical and Surgical Sciences, School of Medicine and Surgery, Università Dalla Campania "L. Vanvitelli", Piazza Miraglia 2, 80138, Naples, Italy.

Antonella Romano (A)

Department of Biology, University of Naples "Federico II", Via Cinthia, 4, 80126, Naples, Italy.

Silvia Bartollino (S)

Department of Medicine and Health Science "V. Tiberio", University of Molise, Campobasso, Italy.

Antonio Porcellini (A)

Department of Biology, University of Naples "Federico II", Via Cinthia, 4, 80126, Naples, Italy.

Ciro Costagliola (C)

Department of Medicine and Health Science "V. Tiberio", University of Molise, Campobasso, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH